Sign In
Pricing

293712 (Harmonized System 2002 for 6-digit)

2022
World Trade $2.51BRnk 1319 / 4939
2022
Top Exporter | Top Importer $1.38B | $1.2BDenmark | China
2022
Product Complexity 0.65Rnk 1457 / 4946
2021 - 2022
Export Growth (CAGR) -12.6%Rnk 4312 / 4939
2022
Share of World Trade 0.011%Rnk 1319 / 4939

About

Overview This page contains the latest trade data of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts. In 2022, Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts were the world's 1319th most traded product, with a total trade of $2.51B. Between 2021 and 2022 the exports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts decreased by -12.6%, from $2.88B to $2.51B. Trade in Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts represent 0.011% of total world trade.

Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts are a part of Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and....

Exports In 2022 the top exporters of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts  were Denmark ($1.38B), United States ($887M), Portugal ($94.9M), India ($42.5M), and France ($28.5M).

Imports In 2022 the top importers of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts were China ($1.2B), Italy ($507M), France ($375M), United States ($133M), and Denmark ($95.8M).

Ranking Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts ranks 1457th in the Product Complexity Index (PCI).

Latest Trends

Latest Data

View
Flow
Y-AXIS SCALE

The following visualization shows the latest trends on Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts. Countries are shown based on data availability.

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

Explore Latest Trends

* Trade values are converted to USD using each month's exchange rate. For December 2023 data, the exchange rate from December 30, 2023 is used.

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Exporters and Importers

Top Origin (2022)Denmark$1.38B
Top Destination (2022)China$1.2B

In 2022 Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts were the world's 1319th most traded product (out of 4,939).

In 2022, the top exporters of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts were Denmark ($1.38B), United States ($887M), Portugal ($94.9M), India ($42.5M), and France ($28.5M).

In 2022, the top importers of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts were China ($1.2B), Italy ($507M), France ($375M), United States ($133M), and Denmark ($95.8M).

Explore Visualizations

Exporters of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts (2022)
[Click to Select a Country]

Importers of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts (2022)
[Click to Select a Country]

Market Dynamics

Color
Top Origin Growth (2021 -  2022)France$10.2M
Top Destination Growth (2021 -  2022)Mexico$10.2M

Between 2021 and 2022, the exports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts grew the fastest in France ($10.2M), Poland ($3.57M), Italy ($3.32M), Switzerland ($1.97M), and Malaysia ($1.67M).

Between 2021 and 2022, the fastest growing importers of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts were Mexico ($10.2M), India ($5.37M), Germany ($3.31M), United States ($3.21M), and Pakistan ($1.77M).

Explore Visualizations

Exporters of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts (2021 - 2022)

Importers of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts (2021 - 2022)

Market Concentration

Value

This chart shows the evolution of the market concentration of exports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts.

In 2022, market concentration measured using Shannon Entropy, was 1.6. This means that most of the exports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts are explained by 3 countries.

Explore Visualizations

Value of Exports in Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts

Net Trade

TOP NET EXPORTER (2022)Denmark$1.29B
TOP NET IMPORTER (2022)China$1.18B

This map shows which countries export or import more of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts. Each country is colored based on the difference in exports and imports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts during 2022.

In 2022, the countries that had a largest trade value in exports than in imports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts were Denmark ($1.29B), United States ($754M), Portugal ($94.9M), Malaysia ($23.7M), and Switzerland ($5.32M).

In 2022, the countries that had a largest trade value in imports than in exports of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts were China ($1.18B), Italy ($504M), France ($346M), Mexico ($28.5M), and Brazil ($18M).

Net Trade (2022)

Country Comparison

Flow
Measure
Ranking

This visualization shows the countries that have an important ratio of their trade related to Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts.
It is possible to select the main countries that export or import Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts in the world, or by continent, as well as select the measure of interest.

Top 10 Exporters Countries of Polypeptide hormones, protein hormones and glycoprotein hormones, their derivatives and structural analogues: insulin and its salts by percentage of total exports

Product Complexity

Diversification Frontier

Specialization

The Complexity-Relatedness diagram compares the risk and the strategic value of a product's potential export opportunities. Relatedness is predictive of the probability that a country increases its exports in a product. Complexity, is associated with higher levels of income, economic growth potential, lower income inequality, and lower emissions.

Relatedness vs Country Complexity (2022)

Keep Exploring

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with
About the OECPrivacy PolicyTerms